ARTICLE | Company News
Angiotech, Alcon end research deal
November 21, 2001 8:00 AM UTC
Angiotech (ANPI; TSE:ANP) and Alcon (Fort Worth, Texas) ended a 2000 deal to develop paclitaxel in a polymeric carrier as a therapeutic agent for proliferative ophthalmic conditions. ANPI said the lea...